tabula rasa healthcare inc trhc  insider monkey companies  see all hedge funds  see all insiders  see all institutional investors  see all click here to see all results for sorry no results has been found matching your query adblocker detected dear valued visitor we have noticed that you are using an ad blocker software although advertisements on the web pages may degrade your experience our business certainly depends on them and we can only keep providing you highquality research based articles as long as we can display ads on our pages to view this article you can disable your ad blocker and refresh this page or simply login we only allow registered users to use ad blockers you can sign up for free by clicking here or you can login if you are already a member home  insider trading  tabula rasa healthcare inc  profile tabula rasa healthcare inc trhc get email alerts profile hedge fund holdings insider purchases insider sales institutional investors holdings news get email alerts profile hedge fund holdings insider purchases insider sales other institutional investors holdings news sector servicesbusiness services nec related insiders h calvin knowlton chief executive officer  v orsula knowlton president  r glen bressner large shareholder director  h calvin knowlton chief executive officer  v orsula knowlton president  r glen bressner large shareholder director  dennis helling director  gordon tunstall director  bruce luehrs director  c daniel lubin large shareholder director  w brian adams chief financial officer  r eric arnson large shareholder  originate growth gp llc large shareholder  originate growth fund a lp large shareholder  j michael gausling large shareholder  originate growth fund q lp large shareholder  jordan davis large shareholder  p l iii partners venture radius large shareholder  radius venture partners iii qp lp large shareholder  radius venture partners iii llc large shareholder  radius venture partners iii ohio lp large shareholder  m joann durham large shareholder  r john durham large shareholder  stage capital ventures associates lp other  stage capital associates gp llc other  emerald stage ventures lp other  show all insiders  insider trading purchases see all insider price amount relationship remaning holdings date form  bressner   large shareholder director   filing bressner   large shareholder director   filing gausling   large shareholder   filing arnson   large shareholder   filing bressner   large shareholder director   filing insider trading sales see all insider price amount relationship remaining holdings date form  knowlton   large shareholder officer director   filing knowlton   large shareholder officer director   filing knowlton   large shareholder officer director   filing knowlton   large shareholder officer director   filing tunstall   director   filing hedge fund resource center how to beat the market by  percentage points why track hedge funds download a free edition why you should dump your hedge funds  things you didnt know about hedge funds billionaire hedge funds warren buffett berkshire hathaway  david einhorn greenlight capital  george soros soros fund management  t boone pickens bp capital  jim simons renaissance technologies  leon cooperman omega advisors  carl icahn icahn capital lp  steve cohen point asset management  john paulson paulson  co  david tepper appaloosa management lp  home hedge funds markets blog authors about us contact us privacy policy terms of use site map all text and design is copyright  koala guide llc all rights reserved mpm capital  powering breakthroughs in life sciences mpm focus area antibody agents for thetreatment of cancerrelated investment costimwatch now chris bardon md oncology impact funddiscusses advances in cancer therapies bloomberg capital markets june  related investment costim companies mpm investment strategy mpm capital works with leading scientists to create companies that seek to address unmet needs and change the face of medicine across all therapeutic areas mpm is currently investing out of bv its most recent venture fund in  mpm partnered with ubs to create the ubs oncology impact fund oif an innovative impact investing fund focused exclusively on oncology that will invest in both private and public equities oif will support both basic cancer research as well as access to cancer care in developing countries fund all bv oncology impact fund investments current exited exit type all ipo ma focus area all oncology other andme genetic reports for consumers to better appreciate their ancestry other current  smallmolecule therapeutics that modulate mirnas for treatment oncology current affymax inc previously committed to developing novel drugs other exited aires clinical stage pharmaceutical company for pulmonary disorders other exited alinea pharmaceuticals inc previously developed new treatments for metabolic conditions other exited allozyne inc cancer and inflammatory disease therapeutic company oncology exited alnara orallydelivered protein therapeutics to treat metabolic diseases other exited amphivena developing bispecific tandabs as a novel immunotherapy for hematological disorders oncology current anthera developing drugs for autoimmune diseases other exited aratana provides innovative therapies for companion animals other current archus orthopedics inc previously developed implants to treat spine disorders other exited aryx therapeutics inc previously focused on molecular design other exited astute medical improving the diagnosis of highrisk medical conditions other current atopix therapeutics inc developing novel treatments for asthma other exited barrier therapeutics inc specialized in dermatological creams and gels other exited biomarin innovative therapeutics to patients with serious unmet medical needs other exited blade therapeutics a discovery stage company focused on developing fibrosis treatments other current celladon developing a transformative therapy for heart failure other exited cellerant therapeutics inc novel immunotherapies for oncology and bloodrelated disorders oncology exited cerecor inc developing innovative treatments for patients with cns disorders other exited ceregene inc development and manufacturing of gene therapies other exited cerimon pharmaceuticals inc developed and commercialized therapeutics for autoimmune diseases other exited chf solutions inc manufactures medical devices for cardiac care other exited chiasma developing oral drugs that were previously only available by injection other current clinical ink modernize clinical trials with esource  patient engagement tools other current conatus developing novel therapeutics for liver diseases other exited costim developing novel antibodies for cancer immunotherapy oncology exited cotherix inc licensing of therapeutic products for cardiopulmonary diseases other exited digitx partners digital health investment partnership with astellas pharma other current dragonfly sciences inc developing a new class of biosimilar products other exited ekr therapeutics provides acutecare specialty products other exited elixir pharmaceuticals inc develops novel pharmaceuticals for the treatment of metabolic diseases other exited endogastric solutions inc endoluminal treatment of gastroesophageal reflux disease other exited endologix provides optimal solutions for endovascular aortic repair other current enteromedics inc developer of vbloc® neurometabolic therapy other current epizyme personalized therapeutics for patients with genetically defined cancer oncology current fortebio develops analytical systems that enable realtime analysis of biomolecular interactions other exited harpoon therapeutics t cell redirection to deliver deep remissions oncology current helicos biosciences corporation genetic analysis for the research drug discovery and diagnostics other exited hypnion inc development of novel therapeutics for cns disorders other exited iconic developing therapeutics for serious eye disorders other current idenix discovers and develops drugs for human viral diseases other exited idun pharmaceuticals inc other exited innovative spinal technologies inc developed treatments for spinal disorders other exited intercell ag modern prophylactic and therapeutic vaccines other exited intracel holdings corporation development and commercialization of cancer vaccines other exited iomx therapeutics ag targeting t cell evasion to treat cancer oncology current ipierian developing antitau protein antibodies for neurodegenerative disease other exited kalobios pharmaceuticals inc developing monoclonal antibodies for cancer care oncology exited macrogenics inc oncology exited maverick therapeutics inc inducible t cellredirecting antibodies oncology current memory pharmaceuticals corp developed drug candidates for the treatment of cns disorders other exited meritage pharma treatment for eosinophilic esophagitis eoe other exited mitobridge discovers and develops novel drugs that enhance mitochondrial function other current motus therapeutics inc developing therapies for severe gastric mobility disorders other exited neosil manufactures dermatologyfocused specialty pharmaceutical products other exited neovista inc technologies for age related mucular degeneration other exited neuromed pharmaceuticals inc produces pain therapies in the us other exited nevro developing a highfrequency stimulation technology for chronic pain other exited oncorus developing a nextgeneration immunotherapy platform to treat cancer oncology current oxagen limited a privatelyheld biopharmaceutical company other current pacira acute care products including exparel for postsurgical analgesia other exited peptimmune inc designs peptides for therapeutics diagnostic kits  antibodies other exited pernix therapeutics inc specialty primary care and generic medicines other exited pharmasset discovering and developing novel drugs to treat viral infections other exited pharmathene inc acquire and develop products identified as urgent priorities other exited poniard pharmaceuticals inc discovery development and commercialization of oncology products other exited portola pharmaceuticals inc a biopharmaceutical company in the hematologic diseases fields other exited potenza therapeutics developing novel immunotherapies for the treatment of cancer oncology current proteon therapeutics developing a therapy to improve dialysis vascular access other current quatrx pharmaceuticals company treatment of moderate to severe dyspareunia fda approved in feb  other exited radius health novel differentiated therapeutics for patients with osteoporosis other current raze therapeutics developing novel antitumor agents through mitochondrial onecarbon me oncology current repare therapeutics targeting geneticallydefined cancer weaknesses oncology current rhythm developing peptide therapeutics for metabolic diseases other current rigel pharmaceuticals inc smallmolecule development for inflammatory and autoimmune diseases oncology exited rinat neuroscience corp develops treatment of diseases and disorders of the nervous system other exited sai drug discovery development and manufacturing services other exited selexys developing novel products to treat inflammatory diseases other exited semma therapeutics developing cellbased transformative therapies for diabetes patients other current sideris pharmaceuticals inc development of new treatments for transfusion related iron overload other exited solasia developing commercializing oncology  oncology supportive care drugs oncology exited somaxon pharmaceuticals inc developed silenor for treatment of insomnia other exited surface logix inc enhancing molecular functionality of pharmaceuticals other exited syndax developing and commercializing epigenetic therapies for cancer oncology current tcr inc focused on engineering t cells for cancer therapy oncology current tercica inc developed increlex for treatment of primary igf deficiency other exited tetherex pharmaceuticals corporation operates in the healthcare industry focusing on biotechnology business other current theraclone sciences inc screening technology for antibodies that ward off disease other exited tizona therapeutics inc regulatory t cell suppression as a novel approach to fighting cancer oncology current trieza therapeutics immunomodulatory oncolytic virus therapeutics oncology current trinetx platform to improve clinical research study design  recruitment other current true north therapeutics developing drugs which selectively inhibit the complement system other exited vaccinogen inc personalized vaccines to fight disease oncology other current valeritas marketing a disposable insulin delivery device other current vascular developing a novel antibody for diabetic nephropathy other current verastem inc treating cancer by the targeted killing of cancer stem cells oncology exited verus pharmaceuticals inc pediatricoriented specialty pharmaceutical company other exited xanodyne pharmaceuticals inc integrated specialty pharmaceutical company other exited mpm team mpms team is comprised of innovators entrepreneurs executives  investors role investment team medical  scientific advisors operations team location all cambridge san francisco patrick baeuerle patrick baeuerle phd managing director cambridge read bio chris bardon christiana bardon md managing director cambridge read bio vinay bhaskar vinay bhaskar phd principal san francisco read bio laura brass laura brass phd mba managing director cambridge read bio lauren cauley lauren cauley chief financial officer cambridge read bio thomas ebeling thomas ebeling medical and scientific advisor oif read bio stephen elledge stephen j elledge phd medical and scientific advisory board mpm  oif read bio luke evnin luke evnin phd managing director san francisco read bio mitchell finer phd mitchell finer phd managing director cambridge read bio todd foley todd foley mba managing director cambridge read bio shinichiro fuse shinichiro fuse phd principal cambridge read bio ansbert gadicke ansbert gadicke md managing director cambridge read bio bard geesaman bard geesaman md phd managing director cambridge read bio william greene william greene md venture partner san francisco read bio william hahn william c hahn md phd medical and scientific advisor oif read bio dan hicklin dan hicklin phd managing director cambridge read bio robert horvitz h robert horvitz phd medical and scientific advisory board mpm  oif read bio ed hurwitz ed hurwitz jd mba managing director san francisco read bio briggs morrison briggs morrison md managing director cambridge read bio vas narasimhan vas narasimhan md medical and scientific advisory board mpm read bio gary patou gary patou md managing director san francisco read bio sarah reed sarah reed chief operating officer and general counsel cambridge read bio tony rosenberg tony rosenberg managing director cambridge read bio david ryan david p ryan md medical  scientific advisor oif read bio kazumi shiosaki kazumi shiosaki phd managing director cambridge read bio greg sieczkiewicz greg sieczkiewicz jd phd managing director  chief ip counsel cambridge read bio elizabeth stoner elizabeth stoner md managing director cambridge read bio chris varma chris varma phd entrepreneurinresidence cambridge read bio contact us infompmcapitalcom cambridge ma  kendall street cambridge ma  phone   see full map  get directions san francisco ca  gateway boulevard suite  south san francisco ca  phone   see full map  get directions print terms of use  disclosures  july   mpm’s chris bardon talks to bioworld about recent pharma rd restructuring trends point to pharma focus on signing more early stage partnerships july   radius health appoints jesper høiland as president and chief executive officer leading the next stage of growth and value creation as a fully integrated commercial biotech company june   semma therapeutics mentioned in wsj article “biotech startups’ cellbased diabetes attack” june   mpm and versant venture colead series a financing of repare therapeutics june   proteon therapeutics announces  million private placement june   visionary scientist stephen j elledge joins mpm capital’s medical and scientific advisory board june   accomplished oncologist and scientist william c hahn joins mpm capital’s oncology impact fund advisory board june   tcr therapeutics to debut positive solid tumor data on its novel truc™ engineered t cell platform at the world preclinical congress june   radius presents positive data from a fully enrolled ongoing phase i study for investigational drug elacestrant rad at the  american society of clinical oncology annual meeting asco may   amgen vet patrick baeuerle inspires a m round from alist vcs for a nextgen io drug platform may   harpoon therapeutics announces completion of m series b financing may   mpm portfolio company true north therapeutics acquired by bioverativ inc upfront payment of m plus assumed cash with additional payments of up to m contingent on the achievement of future milestones may   syndax shares soar as lead drug clears a midstage cancer drug study hurdle may   conatus announces exercise of license option for global development and commercialization of emricasan following notice of initiation of phase b encorelf clinical trial in nash cirrhosis may   inside perspectives on cancer immunotherapy an interview with mpm’s christiana bardon april   fda approves mpm portfolio company radius health’s tymlos™ abaloparatide bone building agent for the treatment of postmenopausal women with osteoporosis at high risk for fracture april   meet one the most successful german biotech leaders ever read more about mpm’s patrick baeuerle april   mpm managing director chris bardon named a top transformer top innovation gurus leading the biopharma industrys transformation are recognized by mmm april   mpm portfolio company oncorus nominated for  nevy award as hottest earlystage startup therapeutics april   syndax pharmaceuticals adds biopharmaceutical industry leader keith a katkin to board of directors february   rhythm announces completion of  million mezzanine financing — proceeds to finance significant expansion of genetic obesity clinical trials — february   chris varma cofounder and former president and ceo of blueprint medicines joins mpm as entrepreneurinresidence january   mpm portfolio company maverick therapeutics and takeda announce fiveyear collaboration to advance tcell engagement therapies january   accomplished biotech investor ed hurwitz joins mpm as managing director  december   mpm portfolio company astute medical forms strategic partnership with biotechne december   novartis signs exclusive option collaboration and license agreement with mpm portfolio company conatus pharmaceuticals inc december   oncorus® inc announces additional series a financing support from astellas venture management llc december   harpoon therapeutics appoints gerald mcmahon phd as president and ceo december   tcr therapeutics launches from stealth mode to accelerate development of novel cancer immunotherapies  m series a financing led by mpm capital and f ventures  december   chris bardon mpm managing director comments to bloomberg on new approaches to medical philanthropy read full article – “a few billionaires are turning medical philanthropy on its head” november   epizyme announces fast track designation for tazemetostat in dlbcl and provides tumor program update november   novartis acquires mpm portfolio company selexys pharmaceuticals corporation and selg antibody for reduction of pain crises in sickle cell disease november   harpoon therapeutics appoints hanspeter gerber phd as chief scientific officer november   semma therapeutics announces mark fishman md has joined its board of directors as chairman october   mpm portfolio company epizyme expands clinical programs through cooperative research and development agreements with the national cancer institute october   motus therapeutics inc a subsidiary of mpm portfolio company rhythm holding co llc is to be acquired by allergan acquisition announced following positive results for phase b clinical trial of treatment for gi disorders october   true north therapeutics receives fda orphan drug designation for tnt for the treatment of autoimmune hemolytic anemia including cold agglutinin disease cad october   pacira pharmaceuticals’ kristen williams is honored as  of  “fierce women in biopharma ” learn why kristen stands out among women in the industry september   iomx therapeutics raises eur  million in series a round company establishes toptier investor base consisting of mpm capital sofinnova partners wellington partners and merck ventures september   three mpm portfolio companies blade oncorus  rhythm named to fiercebiotech’s “ fierce ” list september   radius announces publication of additional positive results from the phase  active trial of osteoporosis treatment september   tizona therapeutics inc appoints george golumbeski phd to its board of directors august   osteoporosis a disease with few treatment options may soon have one more read coverage in ny times and in press release august   aratana secures third fda approval animal pain drug expected to be available to veterinarians in the fall of  august   harvard medical school appoints mpm medical and scientific advisory cochair george daley as new dean read more in the boston globe august   iconic therapeutics announces final close of series c financing with additional  million investment august   astellas and mpm capital launch digitx partners july   mpm portfolio company blade therapeutics featured in the san francisco business times the july  article “taking it personally cutting–edge biotech snags  million” discusses the latest round of funding for blade a company focused on finding therapies for fibrotic disease and mpm cofounder luke evnin’s personal commitment to the cause july   rhythm announces new england journal of medicine publication of setmelanotide phase  data for treatment of pomc deficiency obesity significant weight loss with targeted treatment for patients with rare genetic defect in critical weight regulation pathway july   former bluebird bio blue cso takes the reins at oncorus startup launches with  million series a june   mpm portfolio company semma therapeutics featured in boston globe bostonarea hospitals have teamed up with the harvard stem cell institute and semma therapeutics to make personalized cellbased therapies and organize clinical trials june   chris bardon managing director for the oncology impact fund on bloomberg capital markets discussing advances in cancer therapies as the  asco annual meeting gets underway may   trinetx enters into collaboration with celgene advance clinical trial design and research for nextgeneration medicines planned may   aratana therapeutics granted fda approval of entyce® firstofitskind ghrelin mimetic may   mpm launches  million social impact oncology fund april   ubs cancer fund shows power of impact investing a new oncology fund will finance academic research and access to cancer care in developing countries april   ubs mpm seek big ‘impact’ in cancer drugs with m fund by marie powers bioworld today april   april   ubs raises record  million for oncology impact fund biospacecom  march   aratana therapeutics granted first fda approval galliprant for the control of pain and inflammation associated with osteoarthritis in dogs march   chiasma initiates phase  trial to support european registration of octreotide capsules for patients with acromegaly march   tizona therapeutics inc completes  million series b financing march   radius health submits new drug application to the us food and drug administration for abaloparatidesc for the treatment of postmenopausal women with osteoporosis march   nasdaq welcomes syndax parmaceuticals inc to the nasdaq stock market january   iconic therapeutics closes series c financing  october   semma therapeutics named fiercemedicaldevices’  fierce  august   syndax enters clinical trial collaboration in cancer immunotherapy combining entinostat and atezolizumab august   syndax raises  million in series c financing august   rhythm subsidiary raises  million in oversubscribed financing financing to advance rhythm metabolic incs setmelanotide program for rare genetic disorders of obesity august   epizyme appoints robert bazemore president and chief executive officer july   chiasma inc prices initial public offering of common stock july   taking clinical trials out of the dark ages clinical ink june   briggs w morrison md ceo of syndax appointed key strategic advisor to mpm capital june   chiasma submits new drug application to us fda for octreotide capsules in acromegaly submission based on positive results from phase  clinical trial june   k peter hirth phd joins iconic therapeutics as board member and senior scientific advisor may   mpm capital appoints pablo j cagnoni md former onyx pharmaceuticals president as managing director and ceo of mpm immunotherapy portfolio company vesuvius may   mpm closes  million fund may   andme launches the lupus research study in collaboration with pfizer inc with lupus awareness month underway study aims to build a patient lupus cohort to advance understanding of the disease april   astellas pharma and potenza therapeutics partner to build a portfolio of immunooncology therapeutics exclusive collaboration includes option for astellas to acquire potenza april   novartis international global head ma and licensing anthony rosenberg to join as managing director effective april    to serve as strategic advisor and on mpm portfolio boards to build leading companies  march   biotech startup to fight diabetes on the cellular front semma therapeutics seeks to turn success in stem research lab into a way to encourage insulin production march   semma therapeutics announces  million in funding led by mpm capital to develop cell therapy for treating type  diabetes signs agreement with global pharmaceutical company march   ebb  flow chiasma’s private decision march   chiasma announces mark leuchtenberger as chief executive officer proven business leader to oversee commercialization of octreotide capsules march   andme to create therapeutics group appoints scientific luminary rd executive richard scheller phd to lead dr scheller joins andme’s executive leadership team as chief science officer and head of therapeutics march   mpm capital announces immunooncology pioneer patrick baeuerle to serve as managing director top scientist and drug developer joins mpm senior team advancing breakthroughs and discoveries march   radius rdus announced today that it has acquired the license to develop and market rad in japan dinesh purandare hired former sanofi sanpa oncology executive to the position of senior vice president svp and head of global oncology at radius  february   chiasma announces completion of  million series e financing february   verastem receives orphan drug designation from fda for vs in mesothelioma february   chiasma appoints david stack as chairman of the board john a scarlett md joins board of directors february   syndax says immunooncology discovery happened instead of an ipo february   chiasma inc releases newly published phase  study results show positive outcomes for octreotide capsules in people with acromegaly a serious hormonal disorder february   radius celladon and nevro among top ipos in  mpm has   and  out of the top  january   radius the top performing ipo of  radius which is developing treatments for osteoporosis is up  since pricing its june  initial public offering at   december   radius announces positive phase  topline results december   for venture capital biotech is where it’s really at august   aratana featured startups work on biotech drugs for pets june   true north snags m and sets course for the clinic with a rare disease drug april   ipierian acquired by bristolmyers squibb advances discovery strategy to pursue therapeutics for genetically defined diseases april   iconic therapeutics raises  million to advance clinical development of wet amd program william greene md appointed chief executive officer april   celladon receives breakthrough therapy designation from fda mydicar is first gene therapy reported to receive breakthrough designation from fda’s center for biologics evaluation and research cber february   costim pharmaceuticals inc acquired by novartis january   mpm capital and kleiner perkins caufield  byers top the list of investors with the most  ipos january   epizyme and celgene advance epz dotl inhibitor clinical program to benefit cancer patients with acute leukemias achieving  million clinical proof of concept milestone     x x x radius venture partners iii llc  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors radius venture partners iii llc check out list of companies and businesses related to radius venture partners iii llc find out radius venture partners iii llc address and contact details view other people related to radius venture partners iii llc  coworkers colleagues companions etc address  madison avenue th floor new york  ny companies related to radius venture partners iii llc cikcompany namepositioncompany addresstactile systems technology inc owner  tyler street ne ste  minneapolis athersys inc  new carnegie avenue cleveland tabula rasa healthcare inc owner  strawbridge drive suite  moorestown  radius venture partners iii llc on the web persons related to radius venture partners iii llc  tactile systems technology incnamepositioncitymary e andersonvice president reimbursement minneapolisisaacson andrewminneapolislynn larson blakechief financial officer eden prairierishe bryanminneapolisrishe bryanminneapoliswilliam w burkedirector haywardjanisch danminneapolisjordan davisdirector elmsfordjohnson dougminneapolisrobert j folkeschief operating officer minneapolisgalen management llcstamfordgalen partners international v lpstamfordgalen partners v llcstamfordgalen partners v lp owner stamfordmattys geraldminneapolismattys geraldminneapoliswaldridge ireneminneapolisdavis jordanminneapolisroche kevinminneapolisroche kevinminneapolisdaniel c lubinnew yorkanderson maryminneapolisanderson maryminneapolisthompson maryminneapolisgerald r mattyschief executive officer minneapolisrichard nigondirector minneapolissoderberg peterminneapolisradius venture partners iii l pnew yorkradius venture partners iii ohio lpminneapolisradius venture partners iii qp lpnew yorknigon richardminneapolisbryan rishevice president sales minneapolisfolkes robertminneapolisfolkes robertminneapolisfolkes robertminneapoliskevin h rochedirector minnetonkastephen i shapirodirector new yorkzubeen shroffdirector new yorkpeter h soderbergdirector skaneateles fallsshapiro stephenminneapolismaggie thompsonvp payer rltns  govt affr minneapolisshroff zubeenminneapolisshroff zubeenminneapolispersons related to radius venture partners iii llc  athersys inc  newnamepositioncitylee babissdirector clevelanddavid f briganteargylekurt l brundenvice president clevelandcaduceus private investment iii lpnew yorklaura k campbellsenior vice pres finance clevelandjordan davisdirector elmsfordjordan davisdirector new yorkrobert j deansexecutive vice president clevelandgeorge l diamondargylemilne georgeclevelandvan bokkelen gilclevelandhalter financial investments gp llcargylehalter financial investments lpargyletimothy p halterargylejohn j harringtonexec vice pres and cso clevelandsamuel d isalynew yorksamuel d isalynew yorksamuel d isalynew yorkkola ismailclevelandwyszomlerski jackclevelandharrington johnclevelandismail koladirector clevelandcampbell lauraclevelandbabiss leeclevelandwilliam lehmann jrpresident and coo clevelandfloyd d md loopdirector clevelandrandall lorinclevelanddaniel c lubinnew yorkgeorge m milne jrdirector clevelandwilliam c mulliganclevelandwilliam c mulligandirector clevelandorbimed advisors llc owner new yorkorbimed advisors llcdirector new yorkorbimed capital gp iii llcnew yorkradius venture partners ii llcnew yorkradius venture partners ii lpnew yorkradius venture partners iii l pnew yorkradius venture partners iii qp lpnew yorklorin randalldirector hawthornelorin randalldirector clevelandmarat rosenbergargylemichael b shefferydirector new yorkmichael b shefferydirector new yorkkenneth h traubdirector elmsfordkenneth h traubdirector clevelandbokkelen gil vanchairman and ceo clevelandlehmann williamclevelandjack l wyszomierskidirector kenilworthjack l wyszomierskidirector clevelandpersons related to radius venture partners iii llc  tabula rasa healthcare incnamepositioncitybrian w adamschief financial officer moorestowneric r arnson owner bethlehemglen r bressnerdirector extonjordan daviselmsfordjoann m durham owner moorestownjohn r durham owner moorestownemerald stage ventures lp philadelphiamichael j gausling owner bethlehemdennis hellingdirector moorestowncalvin h knowltonchief executive officer moorestownorsula v knowltonpresident moorestowndaniel c lubindirector new yorkbruce luehrsdirector mcleanoriginate growth fund a lp owner bethlehemoriginate growth fund q lp owner bethlehemoriginate growth gp llcbethlehemradius venture partners iii l pnew yorkradius venture partners iii ohio lpminneapolisradius venture partners iii qp lpnew yorkstage capital associates gp llcphiladelphiastage capital ventures associates lpphiladelphiagordon tunstalldirector william a hawkins iii executive profile  biography  bloomberg july    am et capital markets company overview of ew healthcare partners snapshotpeople  overviewboard memberscommittees executive profile william a hawkins iiisenior advisor ew healthcare partnersagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships background mr william a hawkins iii also known as bill has been a special advisor to the ncontact board since  mr hawkins is the cofounder and chairman of medical device innovation consortium he is a senior advisor at ew healthcare partners he served as the chief executive officer and president at immucor inc since joining in october  until june   he served as an interim chief executive officer of immucor inc since october   he served as chief  executive officer and president of ivd holdings inc until may   he served as senior advisor at tpg capital he served as chief operating officer and president at medtronic minimed inc since may  he served as chief operating officer at medtronic inc from may   to august   and its president since may   he served as chief executive officer at medtronic inc from august   to april   and its senior vice president since january  he served as president at vascular  operating segment at medtronic inc from january  to may  and senior vice president of medtronics vascular business mr hawkins served as president at medtronic vascular inc he joined medtronic in january  from novt corporation where he served as president and chief executive officer from june  to  and april  to  respectively prior to medtronic he served as president and chief executive officer of medical device company novoste corporation where he led the development of its innovative stents he served as president of devices for vascular intervention he served as corporate vice president of american home products corporation from april  to may  and served as its president of the sherwood davis and geck organization mr hawkins served as president at the ethicon endosurgery inc from october  to april  from january  to october  he served as vice president in charge of united states operations of guidant corporation he held several positions with ivac corporation and served as president and chief executive officer from  to  he previously held senior leadership positions at johnson  johnson and eli lilly  co he began his medical technology career with carolina medical electronics in  his career spans more than three decades he was elected as the president of the american institute of medical and biological engineering amibe in  he was appointed as an adjunct professor of engineering at the pratt school in the fall of  mr hawkins has been the chairman and director of tech inc since october   he has been the chairman of board of managers at bioventus llc since january   he has been the chairman of keranetics llc since august  and also serves as its director he has been the chairman of the board at ncontact inc since july   he is the chairman at immucor inc and has been its director since october   and lead director since june   he has been a director of ivd holdings inc since october   he served as chairman of medtronic inc from august   to april   he serves as vice chair and a member of the board of the duke university health system he has been a director of trice medical inc since april   he serves as a director of baebies he sdirector of agency for science technology and research he serves on the board of directors of georgia biomedical partnership and the innovation factory he serves as director of mg biotherapeutics llc mr hawkins has been a trustee of duke university since  he serves as a director of advameddx he has been an independent director of halyard health inc since december   he is also active on public and private boards as well as non for profit boards he serves as a member of board of managers at bioventus llc he serves as a member of advisory board of radius ventures llc and arboretum ventures llc he serves as a member of advisory board at healthquest capital he also serves as a member of the advisory boards at ncontact surgical accuitive medical ventures the astar serc cluster advisory board and the biomedical sciences international advisory council he served as a director of medtronic inc from march  to april   he served as a director of deluxe corporation from may   to august   and novt corporation since may  he served as a director of thoratec corp from january   to october   he served as a director of pharmanetics inc his previous board positions included advamed advanced medical technology association fda executive in residence trustee of the university of virginia darden school of business he was inducted into the national academy of engineering mr hawkins has been a member of research triangle institute since august   in  he was appointed as representative of the board at duke university he was a member of dukes pratt engineering school board of visitors from  to  and served as its chair from  to  he is a veteran entrepreneur and executive in the medical device arena with more than  years of csuite experience in cardiology surgery and vascular therapies mr hawkins received a master of business administration degree from the darden school of business university of virginia in  he received his bachelor of science degree in electrical and biomedical engineering from duke university in  where he also conducted medical research in pathologyread full background corporate headquarters  bryant streetpalo alto california united statesphone fax  board members memberships directoragency for science technology and researchdirectormg biotherapeutics llcchairmankeranetics llcmember of board of managersbioventus llcpresentlead directorimmucor incpresentdirectorivd holdings incpresentmemberresearch triangle institutepresentchairmanncontact incpresentindependent directorhalyard health incpresentdirectortrice medical incpresentchairmantech inc education bs duke universitymba colgate w darden graduate school of business administration other affiliations pharmanetics incmedtronic plcmedtronic minimed incnovt corporationradius ventures llcdeluxe corporationimmucor incthoratec corpresearch triangle instituteduke universitymedtronic vascular incarboretum ventures llccolgate w darden graduate school of business administrationagency for science technology and researchmg biotherapeutics llcncontact inckeranetics llcbioventus inctrice medical incivd holdings inchalyard health inchealthquest capitaltech incbioventus llc annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation there is no total compensation data available request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact ew healthcare partners please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close dag ventures dag ventures open a midstage venture capital partnership with a serviceoriented mindset dag ventures supports visionary entrepreneurs and the elite earlystage vcs whove backed them a few of our investments view all investments brighter building a better dental benefit by seamlessly connecting patients providers and payers to transform the member experience and improve outcomes brightercom close pentaho comprehensive big data platform for data integration and business analytics pentahocom close openx software online advertising tools and services openxcom close chegg online textbook rental ipo nyse chgg cheggcom close proofpoint email security and data loss prevention solutions ipo nasdaq pfpt proofpointcom close our team is built for speed consistency and simplicity meet our team service is our focus in every aspect of our business about dag ventures radius venture partners iii qp lp formdscom  sec filings of fundraisings and investments in hedge funds private equity firms startups and growing companies formdscom newest filter local radius venture partners iii qp lp address  madison avenue th floor new york ny  filings date filingtype reported sold incremental cash type exemptions link to raw filing  paper filing unknown unknown other sec link home  kayne anderson capital advisors lp niche focusedalternative investingresults driven energy  infrastructure a leading alternative investment energy platform private credit adding value through highquality middle market companies real estate targeting highquality offmarket assets in growthoriented sectors growth equity private investing in middle market growth companies pinedale energy partners an affiliate of oak ridge natural resources agrees to acquire pinedale assest from qep resources  frost  sullivan names drivewyze company of the year  native exploration holdings llc receives  million equity commitment from kayne anderson  nathan locke and nishita cummings featured in los angeles business journal article on most influential private equity firms  nathan locke annonced as winner of the th annual emerging leaders awards  facefirst featured in article on research showing how facialrecognition stops shoplifters  valorem energy llc receives  million equity commitment from kayne private energy income fund  kayne anderson acquisition corp completes  million initial public offering  where kayne anderson sees opportunity jc frey featured on bloomberg markets  consumer privacy notice  privacy policy  northern trust   x no bu services in your region bu services are not currently available in region if you would like to learn more about services we offer you may contact us directly or select another region contact us select another region united states europe middle east africa united states europe middle east africa canada asia  australia new zealand united states europe middle east africa canada asia australianew zealand fx algo suite capital markets solutions   privacy policy   consumer privacy notice            share this                         privacy at northern trust  keeping your finances a private matter facts what does northern trust do with your personal information why financial companies choose how they share your personal information federal law gives consumers the right to limit some but not all sharing federal law also requires us to tell you how we collect share and protect your personal information please read this notice carefully to understand what we do what the types of personal information we collect and share depend on the product or service you have with us this information can include social security number and income account balances and payment history credit history and account transactions how all financial companies need to share customers personal information to run their everyday business in the section below we list the reasons financial companies can share their customers personal information the reasons northern trust chooses to share and whether you can limit this sharing reasons we can share your personal information does northern trust share can you limit this sharing for our everyday business purposes — such as to process your transactions maintain your accounts respond to court orders and legal investigations or report to credit bureaus yes no for our marketing purposes — to offer our products and services to you yes no for joint marketing with other financial companies yes no for our affiliates everyday business purposes — information about your transactions and experiences yes no for our affiliates everyday businesses purposes — information about your credit worthiness no we dont share for our affiliates to market to you yes yes for nonaffiliates to market to you no we dont share to limit our sharing you may limit our use or sharing of information about you for marketing purposes by calling   monday through friday  am to  pm central time and saturday and sunday  am to  pm  central time or by stopping in at one of our locationsplease note if you are a new customer we can begin sharing your information  days from the date we sent this notice when you are no longer our customer we continue to share your information as described in this notice however you can contact us at any time to limit our sharing questions contact us at  who we are who is providing this notice northern trust family of companies   what we do how does northern trust protect my personal information to protect your personal information from unauthorized access and use we use security measures that comply with federal law these measures include computer safeguards and secured files and buildings how does northern trust collect my personal information we collect your personal information for example when you open an account or deposit money make deposits or withdrawals from your account or apply for a loan give us your contact information we also collect your personal information from others such as credit bureaus affiliates or other companies why cant i limit all sharing federal law gives you the right to limit only sharing for affiliates’ everyday business purposes — information about your credit worthiness affiliates from using your information to market to you sharing for nonaffiliates to market to you state laws and individual companies may give you additional rights to limit sharing what happens when i limit sharing for an account i hold jointly with someone else your choices will apply only to you — unless you tell us otherwise definitions affiliates companies related by common ownership or control they can be financial and nonfinancial companies our affiliates include companies with a northern trust name financial companies such as the northern trust company nonaffiliates companies not related by common ownership or control they can be financial and nonfinancial  companies northern trust does not share with nonaffiliates so they can market to you joint marketing a formal agreement between nonaffiliated financial companies that together market financial products or services to you our joint marketing partners include northern funds     this privacy notice is provided to you on behalf of one or more of these affiliates and funds the northern trust company equity longshort opportunities fund northern trust securities inc private equity core fund i lp the northern trust company of delaware private equity core fund ii lp the northern trust company of nevada private equity core fund qp ii lp northern trust investments inc private equity core fund iii lp northern trust global investments limited private equity core fund qp iii lp  south capital advisors llc private equity core fund iv lp alpha core strategies fund private equity core fund iv – h holdings llc alpha core strategies feeder fund private equity core fund qp iv lp alpha core strategies feeder fund qp private equity core fund v lp buyout us core fund iii lp private equity core fund qp v lp buyout nonus core fund iii lp private equity core fund vi lp buyout us core fund iv lp private equity core fund qp vi lp buyout nonus core fund iv lp private equity strategic opportunities fund i lp buyout us core fund v lp private equity strategic opportunities fund ii lp buyout nonus core fund v lp systematic alternatives fund llc buyout core fund vi lp systematic alternatives fund ltd diversified core strategies fund llc systematic alternatives master fund lp diversified core strategies fund ltd venture core fund iii lp diversified core strategies master fund lp venture core fund iv lp equity longshort opportunities feeder fund venture core fund v lp equity longshort opportunities feeder fund qp venture core fund vi lp     member fdic       share this            northern trust corporation halter financial investments lp  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors halter financial investments lp check out list of companies and businesses related to halter financial investments lp find out halter financial investments lp address and contact details view other people related to halter financial investments lp  coworkers colleagues companions etc address  hilltop road argyle  tx companies related to halter financial investments lp cikcompany namepositioncompany addressenergroup holdings corpno  xin yi street ganjingzi district dalian city liaoning province china ritar power corproom  tower c huahan building  langshan road north hightech ind pk nanshan dist shenzhen winner medical group incwinner industrial park bulong road longhua shenzhen city orion ethanol inc s main street pratt golden elephant glass technology inc owner  hilltop road argyle sutor technology group ltd south  east  salt lake city china pharma holdings incnd floor no  jinpan road haikou hainan province american lorain corpbeihuan road junan county shandong shengdatech incbuilding  no  wang qiao lu chuansha town pudong xin qu wonder auto technology incno  lingxi street taihe district taihe district redpoint bio corp graphics drive ewing china gengsheng minerals incno  gengsheng road dayugou town gongyi henan international stem cell corp priestly drive carlsbad usa zhimingde international group corp owner  broadway suite  new york whitehall jewelers holdings inc south wacker dr ste  chicago athersys inc  new carnegie avenue cleveland bthc x incst floor chapel house  chapel street guildford surrey gu uctht heat transfer technology inctht industrial park no  nanhuan road tiexi district siping city jilin province bthc xiv inc fm  argyle bthc xv inc fm  argyle chile mining technologies incjorge canning  nunoa santiago smsa treemont acquisition corp fm  argyle enerpulse technologies inc alamo avenue se albuquerque smsa humble acquisition corp fm  argyle smsa shreveport acquisition corp fm  argyle smsa dallas acquisition corp hilltop road argyle  halter financial investments lp on the web persons related to halter financial investments lp  energroup holdings corpnamepositioncityalycia d anthony sandyjames padraic boyleshanghaidavid f briganteargylegeorge l diamondargylematthew dillondalianma fengqindalian citystephen r frysalt lake citystephen r frysalt lake citychen fuyuandalian citynestor gounarisnew yorkhalter financial investments gp llcargyletimothy p halterargylethomas j howellssalt lake cityshi huashandalian citydoolin james salt lake cityduane s jensonsalt lake cityduane s jenson owner salt lake citymarat rosenbergargyleshine gold holdings ltddalianwang shudalian citywang shuyingdalian citysharon xiaorong tangdalian city liaoning provincewenbing wangdalian city liaoning provinceyizhao zhangdalian city fpersons related to halter financial investments lp  china ritar power corpnamepositioncitydavid f briganteargylezhenghua caishenzhengeorge l diamondargylejeff feinberg owner del marjeff feinberg owner rancho santa fehalter financial group gp llcargylehalter financial group lpargylehalter financial investments gp llcargyletimothy p halterargyledegang heshenzhenjiada huceo pres sec treasurer shenzhenjiada huchief executive officer shenzhenjiada huchief executive officer nanshan district shenzhenaijun liunanshan district shenzhencharles c monanshan district shenzhenhenying peng owner shenzhenhenying peng owner shenzhenpope asset management llc owner memphispope investments ii llc owner memphispope investments llc owner memphispope investments llc owner memphismarat rosenbergargyleyaofu tangnanshan district shenzhenxiongjie wangnanshan district shenzhenjianjun zengshenzhenpersons related to halter financial investments lp  winner medical group incnamepositioncitydavid f briganteargylejiagan chenshenzhengeorge l diamondargylexiuyuan fangshenzhenxiuyuan fangcfo vp and treasurer shenzhenlarry goldmandirector suffernrichard b goodnerdirector colleyvillehalter financial investments gp llcargyletimothy p halterargylenianfu huozhuhainianfu huosenior vice president zhuhaihongwei jiashenzhenjianquan lishenzhenjianquan liceo and president shenzhenjianquan liceo and president shenzhenjianquan liceo  president longhua shenzhenjianquan liceo  president longhua shenzhenjianquan liceo  president shenzhenmarat rosenbergargylehorngjon shiehkowloonping tseshenzhenping tse owner shenzhenpersons related to halter financial investments lp  orion ethanol incnamepositioncityjoshua barkerprattjoshua barkerexecutive vprisk management prattpatrick barkerprattpatrick barkerchairman pratttimothy c barkerpratttimothy c barkerexec vp  development prattdavid f briganteargylegeorge l diamondargylegary c evanspresident  ceo prattgreengroup ethanol llc owner prattgreengroup llc owner pratthalter financial investments gp llcargyletimothy p halterargylelane hammprattlance w helfertventurah richard jarboeprattjeffrey d jensonsalt lake cityjeffrey d jensonpresident woodscrossj porter loomisprattr atticus loweventurajoseph lewis meibergen iiienidfrank hayden mooreprattjerry vernon nashprattjerry vernon nashexec vp of distribution prattpaul j orfaleaventuramarat rosenbergargylesnb associates llc owner prattwallace a stanberryshreveportwest coast asset management incventurawest coast opportunity fund llcventurapersons related to halter financial investments lp  golden elephant glass technology incnamepositioncitydavid f brigante owner argylegeorge l diamond owner argylegeorge l diamondargylewilliam o fleischmanhalter financial investments gp llc owner argyletimothy p halterpresident ceo secretary cfo argyleqiang haofuxin cityhe lifuxin citymoney victory ltdtortolamarat rosenberg owner argylelihui songpresident ceo and chairman fuxin cityhong tanfuxin citylin tan owner fuxin cityyan tanfuxin citywf investment corpwf nevstar llcwinwin global investments inctortolaguangli yangfuxin cityfuyi zhaofuxin citypersons related to halter financial investments lp  sutor technology group ltdnamepositioncitydavid f briganteargylelifang chendirector changshulifang chenceo changshugeorge l diamondargylepaul lynn dixonsalt lake cityfeng gao owner shanghaipascale gerardchangshuliuhua guochangshushao guoyouchangshuhalter financial investments gp llcargyletimothy p halterargyleheather leigh hambysalt lake cityyongfei jiangchangshuyongfei jiangcfo changshuthomas glenn kimblesalt lake cityxinchuang lichangshuchen lifangchangshucarl muddchangshucarl mudddirector changshu prccarl mudddirector changshu prczhou naijiangchangshuguoxiang nichangshugerard pascaledirector hilton headmarat rosenbergargyleguoyou shaochangshutotal raise investments ltdchangshuzhuo jason wangchangshuli xinchuangchangshushoubin xiongchangshushoubin xiongchief operating officer changshujun xuchangshujun xuchief financial officer changshulin yangchangshuxun zhangchangshunaijiang zhouchief financial officer changshu jiangsunaijiang zhouvice president of finance changshunaijiang zhouchief financial officer changshunaijiang zhouchief financial officer changshupersons related to halter financial investments lp  china pharma holdings incnamepositioncitydavid f briganteargylegeorge l diamondargylebaowen dongchengdu sichuanhalter financial investments gp llcargyletimothy p halterceo pres cfo chairman  sec argylezhilin lihaikouzhilin lipresident and ceo haikouzhilin lipresident and ceo haikoumarat rosenbergargyleheung mei tsuihong kongheung mei tsuidirector hong kongfrank waungchief financial officer short hillsxinhua wuhaikoujian yanghaikouyingwen zhangchengdu fpersons related to halter financial investments lp  american lorain corpnamepositioncityhisashi akazawashandonghisashi akazawa owner osakahisashi akazawa owner osaka mojin alanshandongtad m ballantyneshandongdavid f briganteargylehao chendirector shandongsi chenchairman and ceo shandongsi chenchief executive officer shandongdavid yaudoon chiangshandongdavid yaudoon chiangdirector shandongdimitri cocorinis owner salt lake cityterry cononelos owner salt lake citychiang davidshandong deutsche investitions und entwicklungsgesellschaft mbh degkolnyin dekaishandonggeorge l diamondargylehalter financial investments gp llcargyletimothy p halterargylechen haoshandongyilun jinshandongyilun jinchief financial officer shandongkfwfrankfurt am mainyongjun lishandongwei maoquandirector shandongwei maoquanshandongmarat rosenbergargylehuanxiang shenshandongchen sishandongchen sishandongballantyne tadshandongjing wushandongpeng bo wushandongdekai yindirector shandongli yongjunshandonglu yundongchief operating officer shandonglu yundongshandongxiang zhouchief financial officer shandongxiaodong zhoushandongpersons related to halter financial investments lp  shengdatech incnamepositioncitycapital management de adventnew yorkangelo gordon  co lpnynew yorkjohn m angelonew yorkaqr capital management llcgreenwichbessemer investment management llcnew yorkalan brandysvancouveralan brandysceo cfo  president surrey bc vx gdavid f briganteargylandrew chentaian city shandong provincexiangzhi chentaian city shangdong provcnh partners llcgreenwichdaiwa america strategic advisors corpnew yorkgeorge l diamondargylemichael l gordonnew yorkanhui guotaian cityhalter financial investments gp llcargyletimothy p halterargyledouglas hoppervancouverdouglas hoppersecretary  vice president burnaby bc ve gmichael d kangsan franciscolazard asset management llc new yorklinden advisors lpnew yorkcarl mudddirector taian city shandong providencmarat rosenbergargylesheldon b saidmandirector taian city shandong providencinvestment advisors wellesleywellesleydongquan zhangtaian cityxueyi zhangtaian citypersons related to halter financial investments lp  wonder auto technology incnamepositioncitydavid f briganteargyleye chenmcleanchoice inspre ltdjinzhou citychoice inspre ltd owner jinzhou lianingraymond r cottrellpresidentsecreatry treasurer las vegasgeorge l diamondargyleempower century ltdjinzhou cityempower century ltd owner jinzhou lianingxiangdong gaojinzhoularry goldmandirector suffernlarry goldmandirector jinzhou liaoninghalter financial investments gp llcargyletimothy p halterargylehong humcleanaijun jiangaijun jiangchief financial officer beijinglei jiangbejingrachel pin kangmcleanseuk jun kimjinzhou cityseuk jun kimvp of new product development jinzhou liaoningseuk jun kimvp of new product development jinzhou city lianingzhi limcleanzhi lidirector mcleanyongdong liujinzhou cityyongdong liuvice president of production jinzhou liaoningyongdong liuvice president of production liaoningyuncong majinzhou cityyuncong machief operating officer jinzhou liaoningyuncong machief operating officer liaoningdavid francis murphynew yorkmytop international incmcleanpin kang rachelpresident  secretary mc leanmarat rosenbergargylexianzhang wangjinzhoumeirong yuanjinzhou citymeirong yuancfo and treasurer jinzhou liaoningmeirong yuancfo and treasurer jinzhou city lianingqingdong zengjinzhou liaoningxiaoyu zhangjinzhouqingjie zhaojinzhou city lianingqingjie zhaoceo and president jinzhou lianingqingjie zhaoceo and president jinzhou liaoningqingjie zhaoceo and president liaoningqingjie zhaoceo and president jinzhou city liaoningqingjie zhaoceo and president jinzhou city liaoningyuguo zhaojinzhou cityyuguo zhaovp of sales and marketing jinzhou liaoningyuguo zhaovp of sales and marketing liaoningpersons related to halter financial investments lp  redpoint bio corpnamepositioncitybloom allenphiladelphiaallen bloomdirector ewingdavid f briganteargylerobert bryantcranburyrobert bryantvp  discovery research ewingcargill incwayzata minnesotacargill inc owner wayzatarobert m chefitzcranburygeorge l diamondargyleplc glaxosmithkline owner brentford middlesexplc glaxosmithklinetw gs englandhalter financial investments gp llcargyletimothy p halterargylemichael e heitzlexingtonscott horvitzcranburyscott horvitzchief financial officer ewingscott horvitzphiladelphialeif kjaergaardcranburyleif kjaergaarddirector ewingdavid patchencranburyshanley richardphiladelphiachefitz robertphiladelphiamarat rosenbergargylefrancis raymond salemmecranburyfrancis raymond salemmeceo  president ewingirwin scherdirector ewingrichard p shanleyewing new jerseyrichard p shanleydirector ewingscott a siegelvp  corporate development ewingphilip l smithcranburysusan welshcranburypersons related to halter financial investments lp  china gengsheng minerals incnamepositioncityzhengyong bihenandavid f briganteargylegeorge l diamondargylejeffrey friedlandgongyilarry goldmandirector suffernhalter financial investments gp llcargyletimothy p halterargyleming hedayugou town gongyi nenanming hedirector gongyi henanbo huhenanhongfong jinhenanshuxian lixinzhengningfang liangsecaucushsini lingongyi henanglenn littlemidlandmarat rosenbergargylejingzhong yuwuhan hubeishunqing zhanghenanshunqing zhangceo and president gongyi henanshunqing zhanggongyi henanweina zhanggongyi henanningsheng zhouluoyangpersons related to halter financial investments lp  international stem cell corpnamepositioncitywilliam b adamsoceansidewilliam b adamschief financial officer los angeleswilliam b adamschief financial officer los angeleskenneth c aldrichoceansidekenneth c aldrich owner pacific palisadeskenneth c aldrichchairman  evp pacific palasadeskenneth c aldrichchairman  evp pacific palisadeskenneth c aldrichchairman  ceo pacific palisadeskenneth c aldrichchairman  ceo pacific palisadeskenneth c aldrichdirector pacific palisadeskenneth c aldrichchairman  ceo oceansidekenneth c aldrichdirector pacific palisadeskenneth c aldrichdirector oceansidesemechkin andreycarlsbadar partners llccarlsbadsofya bakalovavp legal affairs  operations carlsbadsofya bakalovadir of legal affairs  oper carlsbadjames h berglundcarlsbadjames h berglunddirector carlsbaddavid f briganteargylecharles j casamentodirector union citycharles j casamentodirector oceansidecharles j casamentodirector carlsbadcharles j casamentodirector carlsbadcasamento charlescarlsbadjohn simon crawexecutive vice president carlsbadgeorge l diamondargylewright dondirector oceansidewright doncarlsbadwright dondirector carlsbadwright dondirector everettwright dondirector everrettwright dondirector everettwright dondirector everettwright dondirector oceansidewright dondirector oceansidewright dondirector carlsbadwright donaldcarlsbadmahnaz ebrahimichief financial officer carlsbadhalter financial investments gp llcargyletimothy p halterargyleedward o hunterdirector irvineedward o hunterdirector irvineberglund jamescarlsbadjeffrey januspresident oceansidejeffrey januspresident oceansidejeffrey januspresident oceansidejeffrey janusvice president operations oceansidejeffrey janussenior vice president oceansidejeffrey janusdirector carlsbadnovak jaycarlsbadjeff krstichoceansidemay kurtcarlsbadnguyen linhcarlsbadbrian lundstrompresident oceansidepaul v maierdirector san diegopaul v maierdirector oceansidepaul v maierdirector oceansidepaul v maierdirector carlsbadpaul v maierdirector carlsbadpaul v maierdirector oceansidepaul v maierdirector oceansidepaul v maierdirector oceansidekurt andrew maycarlsbadlinh t nguyenchief financial officer carlsbadtibor jay novakchief financial officer carlsbadmaier paulcarlsbadmarat rosenbergargylesemechkin ruslancarlsbadandrei semechkinchief executive officer amherstandrei semechkinchief executive officer amherstandrei semechkinchief executive officer carlsbadandrei semechkinchief executive officer carlsbadandrey semechkinceo carlsbadandrey semechkinchief executive officer carlsbadandrey semechkinchief executive officer carlsbadandrey semechkinchief executive officer carlsbadrouslan semechkinevp and cso amherstrouslan semechkindirector amherstruslan semechkinchief scientific officer carlsbadcraw simoncarlsbadbakalova sofyacarlsbadedmund r woodcfo oceansideedmund r woodcfo  secretary oceansideedmund r woodcfo oceansidexmaster inc owner amherstxmaster inc owner amherstpersons related to halter financial investments lp  usa zhimingde international group corpnamepositioncitydavid f briganteargylegeorge l diamondargylehalter financial investments gp llcargyletimothy p halterargyleglenn littlemidlandmarat rosenbergargyleusa zhimingde international group incnew yorkzhongquan zounew yorkpersons related to halter financial investments lp  whitehall jewelers holdings incnamepositioncitydavid f briganteargyleedward dayoobchicagogeorge l diamondargylemichael donchicagojonathan duskinnew yorkisrael a englandernew yorkmark funasakichicagoefrem gerszbergchicagohalter financial investments gp llcargyletimothy p halterargyledavid l harrischicagoseymour holtzmanwilkes barrewilliam r lazorchicagopeter g michieluttiexecutive vp and cfo chicagomillennium management llcnew yorkmillennium partners lpnew yorkrobert b nachwalterchicagocharles phillipsnew yorkdaniel plattnew yorkprentice capital management lpnew yorkmarat rosenbergargylesteve seplaksenior vp merchandising chicagomichael zimmermannew yorkpersons related to halter financial investments lp  athersys inc  newnamepositioncitylee babissdirector clevelanddavid f briganteargylekurt l brundenvice president clevelandcaduceus private investment iii lpnew yorklaura k campbellsenior vice pres finance clevelandjordan davisdirector elmsfordjordan davisdirector new yorkrobert j deansexecutive vice president clevelandgeorge l diamondargylemilne georgeclevelandvan bokkelen gilclevelandhalter financial investments gp llcargyletimothy p halterargylejohn j harringtonexec vice pres and cso clevelandsamuel d isalynew yorksamuel d isalynew yorksamuel d isalynew yorkkola ismailclevelandwyszomlerski jackclevelandharrington johnclevelandismail koladirector clevelandcampbell lauraclevelandbabiss leeclevelandwilliam lehmann jrpresident and coo clevelandfloyd d md loopdirector clevelandrandall lorinclevelanddaniel c lubinnew yorkgeorge m milne jrdirector clevelandwilliam c mulliganclevelandwilliam c mulligandirector clevelandorbimed advisors llc owner new yorkorbimed advisors llcdirector new yorkorbimed capital gp iii llcnew yorkradius venture partners ii llcnew yorkradius venture partners ii lpnew yorkradius venture partners iii l pnew yorkradius venture partners iii llcnew yorkradius venture partners iii qp lpnew yorklorin randalldirector hawthornelorin randalldirector clevelandmarat rosenbergargylemichael b shefferydirector new yorkmichael b shefferydirector new yorkkenneth h traubdirector elmsfordkenneth h traubdirector clevelandbokkelen gil vanchairman and ceo clevelandlehmann williamclevelandjack l wyszomierskidirector kenilworthjack l wyszomierskidirector clevelandpersons related to halter financial investments lp  bthc x incnamepositioncitydavid f briganteargylegeorge l diamondargylemichael e fascicfo treasurer secretary e tauntonpierre galoppipresident cfo  secretary coral gableshalter financial investments gp llcargyletimothy p halterargylemagellan alpha investments corpathensmarat rosenbergargylegeorge syllantavosathensgeorge syllantavospresident and ceo voula  athenspersons related to halter financial investments lp  tht heat transfer technology incnamepositioncitydavid f briganteargylejingxun chenscarboroughyue cuisipinggeorge l diamondargylehalter financial investments gp llcargyletimothy p halterargylewilliam p hausplanojianjun hesipinginfinity ichina fund cayman lptel avivinfinity ichina fund changzhou lpchangzhou jiangsu provinceinfinity ichina fund israel  lptel avivinfinity ichina fund israel  lptel avivinfinity ichina fund israel lptel avivinfinity ichina fund suzhou lpsuzhou jiangsu provinceyoujun liansiping city jilin provincegerard pascalepresident cfo  secretary hilton headariel poppelsiping city jilin provincemarat rosenbergargylewenquan taosipingto tsangsipingwisetop international holdings ltdsipingwisetop international holdings ltd owner jilin provincefucai zhansipingguohong zhaosipingguohong zhaochief executive officer siping jilin provincejinghua zhaosipingjinghua zhao owner siping jilin provincepersons related to halter financial investments lp  bthc xiv incnamepositioncitydavid f briganteargylegeorge l diamondargylehalter financial investments gp llcargyletimothy p halterargylemarat rosenbergargylepatrick d souterdallaspersons related to halter financial investments lp  bthc xv incnamepositioncitydavid f briganteargylerongguang chenshandonggeorge l diamondargylehalter financial investments gp llcargyletimothy p halterargylexianghai kongshandongmarat rosenbergargylexinbo yushandongshanjiu zhangshandongpersons related to halter financial investments lp  chile mining technologies incnamepositioncitysejas alainsantiagojose luis munoz avilessantiagodavid f briganteargyledavid f brigante owner argylegeorge l diamondargylegeorge l diamond owner argylepierre galoppicoral gablespascale geraldsantiagohalter financial investments gp llcargylehalter financial investments gp llc owner argyletimothy p halterargyletimothy p halter owner argyleinversiones orellana uno ltdasantiagoinversiones pizarro rodriguez uno ltdasantiagovergara ivansantiagochristopher mclean jsantiagopizarro jorgesantiagoorellana jorgesantiagoaviles josesantiagoj christopher mcleansantiagojorge osvaldo orellana orellanasantiagogerard pascalehilton headarriagada jorge fernando pizarrosantiagomarat rosenbergargylemarat rosenberg owner argylealain orellana sejassantiagohuerta ivan orlando vergarasantiagopersons related to halter financial investments lp  smsa treemont acquisition corpnamepositioncitydavid f briganteargylegeorge l diamondargylehalter financial investments gp llcargyletimothy p halterargyleguangyin mengshandong provincewencai panshandong provincemarat rosenbergargyleshoubing tangshandong provinceguo wangshandong provinceqingtai wangshandong provincexuchun wangshandong provincedianshun zhangshandong provincepersons related to halter financial investments lp  enerpulse technologies incnamepositioncityaltira group llcdenveraltira group llcdenverdavid f briganteargyletempleton bryanalbuquerquetempleton bryanalbuquerquelouis s camillipres cto  secretary albuquerquegeorge l diamondargyletim forddirector albuquerquejoseph e gonnelladirector albuquerquejoseph e gonnellachief executive officer albuquerqueira a greensteindirector newarkf henry habicht iialbuquerquehalter financial investments gp llcargyletimothy p halterargylemichael j hammonsdirector albuquerquemichael j hammonsalbuquerquegonnella josephalbuquerquegonnella josephalbuquerquematthew liptonfarmers branchcamilli louisalbuquerquecamilli louisalbuquerquehammons michaelalbuquerquehammons michaelalbuquerquejohn r novakvp  oem sales albuquerquepassaic river capital llc owner passaicmarat rosenbergargylesail exit partners llcirvinesail venture management llcirvinesail venture partners ii llcirvinesail venture partners ii lpirvinestephen frederick smithvp  manufacturing  ops albuquerquesvp ii xtreme power joint venture lpirvinebryan c templetoncfo  treasurer albuquerquebryan c templetoncfo  treasurer albuquerqueford timalbuquerqueford timothyalbuquerquepersons related to halter financial investments lp  smsa humble acquisition corpnamepositioncitydavid f briganteargylegeorge l diamondargylepierre galoppicoral gablespierre galoppidirector coral gableshalter financial investments gp llcargyletimothy p halterargylemarat rosenbergargylepatrick d souterdallaspersons related to halter financial investments lp  smsa shreveport acquisition corpnamepositioncitydavid f briganteargylegeorge l diamondargylehalter financial investments gp llcargyletimothy p halterargylemarat rosenbergargylepersons related to halter financial investments lp  smsa dallas acquisition corpnamepositioncitydavid f briganteargylegeorge l diamondargylehalter financial investments gp llcargyletimothy p halterargylemarat rosenbergargyle potentially same personnamecitycountryhalter financial investments lpargyletx